VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 229 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,178 | -3.8% | 1,940 | +151.9% | 0.00% | – |
| Q2 2023 | $18,888 | +9.0% | 770 | +3.4% | 0.00% | – |
| Q1 2023 | $17,336 | -6.7% | 745 | +1.5% | 0.00% | – |
| Q4 2022 | $18,577 | +85.8% | 734 | +33.5% | 0.00% | – |
| Q3 2022 | $10,000 | -60.0% | 550 | -44.0% | 0.00% | – |
| Q2 2022 | $25,000 | +177.8% | 982 | +175.1% | 0.00% | – |
| Q1 2022 | $9,000 | -25.0% | 357 | +22.7% | 0.00% | – |
| Q4 2021 | $12,000 | -33.3% | 291 | -29.9% | 0.00% | – |
| Q3 2021 | $18,000 | -55.0% | 415 | -72.3% | 0.00% | – |
| Q4 2020 | $40,000 | -21.6% | 1,500 | 0.0% | 0.00% | – |
| Q3 2020 | $51,000 | -16.4% | 1,500 | 0.0% | 0.00% | – |
| Q2 2020 | $61,000 | – | 1,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD | 22,616,666 | $284,405,000 | 3.12% |
| INDUS CAPITAL PARTNERS, LLC | 681,936 | $8,575,000 | 1.68% |
| Alphabet Inc. | 1,666,666 | $20,958,000 | 1.27% |
| Temasek Holdings (Private) Ltd | 5,499,999 | $69,162,000 | 0.45% |
| Board of Trustees of The Leland Stanford Junior University | 38,905 | $490,000 | 0.06% |
| Baillie Gifford | 500,000 | $6,287,000 | 0.01% |
| Marshall Wace North America L.P. | 74,898 | $941,000 | 0.01% |
| Capital International Investors | 983,300 | $12,365,000 | 0.00% |
| Blackstone Inc. | 35,000 | $440,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,908 | $24,000 | 0.00% |